| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Dyne Therapeutics, Inc. | Director | Common Stock | 0 | $0 | $28.73 | 18 Nov 2024 | Direct |
| Dyne Therapeutics, Inc. | Director | Stock option (right to buy) | 35,000 | 30 May 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| DYN | Dyne Therapeutics, Inc. | 30 May 2025 | 1 | $0 | 4 | Director | 03 Jun 2025, 21:38 |
| DYN | Dyne Therapeutics, Inc. | 18 Nov 2024 | 3 | -$330,660 | 4 | Director | 18 Nov 2024, 19:42 |
| DYN | Dyne Therapeutics, Inc. | 22 May 2024 | 1 | $0 | 4 | Director | 24 May 2024, 17:10 |
| DYN | Dyne Therapeutics, Inc. | 24 May 2023 | 1 | $0 | 4 | Director | 25 May 2023, 18:37 |
| DYN | Dyne Therapeutics, Inc. | 02 Mar 2022 | 1 | $0 | 4 | Director | 04 Mar 2022, 17:23 |
| DYN | Dyne Therapeutics, Inc. | 02 Mar 2022 | 0 | $0 | 3 | Director | 04 Mar 2022, 17:21 |